Obesity

George Mason trial: New pill aims to sustain weight loss after GLP-1s.

Wegovy injections vs. pills: Doctors explain the differences.

A Wegovy Pill Was Just Approved. Your 5 Top Questions, Answered

The Department of Nutrition and Food Studies was chosen as one of six trial sites for its expertise in obesity and weight loss.

Don’t cheer the end of America’s obesity crisis just yet.

Cheskin, a George Mason Distinguished University Professor, has devoted his career to the research, treatment, and advocacy of obesity prevention and treatment.

Obesity Statistics and Facts In 2025

The associations of objective, behaviorally measured hunger and weight-related variables with Food Craving Inventory subscales in adults with obesity

Food noise: definition, measurement, and future research directions.

After Novo and Lilly resolved GLP-1 shortages, where does the compounding industry stand? Experts weigh in